Castle Biosciences (CSTL) analyst forecast and price target
Analyst forecast
Consensus of 9 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $44.00 from $40.00 | Aug 3, 2026 |
| Roth Capital | Initiated Coverage | Buy | $40.00 | Jun 25, 2026 |
| BTIG | Maintained | Buy | $40.00 from $50.00 | May 13, 2026 |
| Baird | Maintained | Outperform | $43.00 from $44.00 | May 7, 2026 |
| Canaccord Genuity | Maintained | Buy | $40.00 from $50.00 | Apr 20, 2026 |
| Baird | Maintained | Outperform | $44.00 from $41.00 | Feb 27, 2026 |
| Guggenheim | Maintained | Buy | $47.00 from $43.00 | Jan 26, 2026 |
| Lake Street | Maintained | Buy | $52.00 from $35.00 | Jan 12, 2026 |
| Guggenheim | Maintained | Buy | $43.00 from $30.00 | Jan 5, 2026 |
| Canaccord Genuity | Maintained | Buy | $50.00 from $37.00 | Dec 22, 2025 |
| BTIG | Maintained | Buy | $50.00 from $38.00 | Dec 12, 2025 |
| BTIG | Maintained | Buy | $38.00 from $32.00 | Nov 5, 2025 |
| Baird | Maintained | Outperform | $41.00 from $39.00 | Nov 4, 2025 |
| Canaccord Genuity | Maintained | Buy | $37.00 | Sep 9, 2025 |
| Scotiabank | Maintained | Sector Outperform | $40.00 from $44.00 | May 21, 2025 |
| Canaccord Genuity | Maintained | Buy | $37.00 from $42.00 | May 6, 2025 |
| Lake Street | Maintained | Buy | $35.00 from $40.00 | May 6, 2025 |
| Baird | Maintained | Outperform | $37.00 from $36.00 | Feb 28, 2025 |
| Stephens & Co. | Maintained | Overweight | $41.00 | Jan 2, 2025 |
| Scotiabank | Maintained | Sector Outperform | $44.00 from $37.00 | Nov 6, 2024 |
Frequently asked questions
Is CSTL a buy, sell, or hold?
Analysts covering Castle Biosciences currently average a Buy rating: 9 buy, 0 hold and 0 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on CSTL?
On Aug 3, 2026, BTIG maintained Castle Biosciences at Buy with a price target of $44.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.